Kyowa Kirin Co., Ltd.

This study tests a new drug called KK2260 in people with advanced or metastatic solid tumors (cancers that have spread). It is the first time this drug is being used in humans. The study has three parts: first, finding the safest dose; then testing different dosing schedules in e…

This early-phase study tests a new drug called KK2845 in adults whose acute myeloid leukemia has returned or not responded to standard treatments. The main goal is to find the safest dose and check for side effects. About 72 participants will take part in two stages: first to fin…

This early-stage study tests a new medicine called KK3910 in healthy volunteers and people with high blood pressure. The main goal is to check safety and how the drug moves through the body. About 160 Japanese participants will take either the drug or a placebo.

This study is the first time the experimental drug KK2269 is being tested in people. It aims to check the safety of KK2269 given alone or with the chemotherapy drug docetaxel. The trial involves about 101 adults with advanced solid tumors (like stomach, lung, or esophageal cancer…

This study tests a new medicine called KK8123 for adults with X-linked hypophosphatemia (XLH), a rare genetic condition that causes low phosphorus levels and bone problems. The trial has two parts: first, finding the right dose, then checking long-term safety. About 24 adults age…

This study watches how safe and effective the drug mogamulizumab is for adults with mycosis fungoides or Sezary syndrome, two rare types of skin lymphoma. About 15 people will be followed during their normal treatment to track side effects and how well the drug controls the disea…